Solute carrier family 23 member 2 is a protein that in humans is encoded by the SLC23A2 gene. The SLC23A2 gene maps to chromosome 20p12.2-12.3 and is ten times larger than SLC23A1, being 158398 bp long and containing 17 exons. The SLC23A2 variant is a truncated protein resulting from a 345 bp deletion, which excludes the 5 and 6 TM domains and part of the 4 TM domain. SLC23A2 mRNA levels are increased by fetal bovine serum and epidermal growth factor in the human trophoblast cell line and by glucocorticoids, zinc and Ca2+ phosphate ions in osteoblastic cells.
|Basic Information of SLC23A2|
|Protein Name||Solute carrier family 23 member 2|
|Aliases||Na(+)/L-ascorbic acid transporter 2, Nucleobase transporter-like 1 protein, Sodium-dependent vitamin C transporter 2, hSVCT2, Yolk sac permease-like molecule 2|
|Organism||Homo sapiens (Human)|
SLC23A2 is modulated by Ca2+ and Mg2+ ions, that switch the transporter from an inactive form into an active form. In addition, SLC23A2 may be localized intracellularly or on the plasma membrane. A human trophoblast cell line and human first-trimester chorionic villi can express SLC23A2, which is crucial for vitamin C transplacental transfer from the maternal to the fetal circulation. In the brain, SLC23A2 is present in neuroepithelial cells of the choroid plexus, allowing the ascorbate transport in cerebrospinal fluid, as well as in neurons. Indeed, SLC23A2-deficient neuronal cells showed reduced neurite outgrowth and neuronal activity, as well as increased susceptibility to oxidative damage. SLC23A2 is located at the basolateral surface, where it should be involved in vitamin C transport from blood into enterocytes. SLC23A2 overexpression leads to osteoblast differentiation, mineralization and calcium deposition. SLC23A2 also mediates ascorbate uptake in chondrocytes, allowing cartilage to store vitamin C needed for the synthesis of type II collagen in the extracellular matrix.
Fig.1 Schematic model of the uptake and compartmentalization of vitamin C in the CNS. (Nualart, 2014)
The article shows that significant methylation changes in the SLC23A2 and NCOR2 regulatory regions correlate with spinal muscular atrophy severity.
The article reveals that squamous cell carcinoma of the head and neck is highly affected by environmental factors when compared with the effect of SLC23A2-05 and KRAS-LCS6 polymorphisms.
Authors give a conclusion that further investigations with a larger number of patients or an in vitro study are needed to confirm the predictive values of genetic polymorphisms in SLC23A2.
This article demonstrates a high gene expression of SLC23A1 but no expression of SLC23A2 in the proximal convoluted and straight tubules of humans.
This article shows that SLC23A2 genetic variation alters the risk of HPV16-associated head and neck cancer, while also highlights the important role of citrus exposure in this disease.
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC23A2 antibody development services.
Creative Biolabs' skillful scientists are glad to leverage our expertise and advanced technologies to help you in the member protein research. If you are interested, please feel free to contact us for more details.